Author:
Aizenberg Marisa,Brandolini Andrés
Publisher
Springer International Publishing
Reference62 articles.
1. Alemayehu, D., Hemmings, R., Natarajan, K., & Roychoudhury, S. (2021). Perspectives on virtual (remote) clinical trials as the “new Normal” to accelerate drug development. Clinical Pharmacology & Therapeutics.
2. Angeletti, F., Chatzigiannakis, I., & Vitalett, A. (2018). Towards an architecture to guarantee both data privacy and utility in the first phases of digital clinical trials. Department of Computer, Control, and Management Engineering “Antonio Ruberti”, Sapienza University of Rome.
3. Asociación Médica Mundial. Declaración de Helsinki. (1964). https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/
4. Brezing, C. A., Luo, S. X., Mariani, J., & Levin, F. R. (2020). Digital clinical trials for substance use disorders in the age of Covid-19. Journal of Addiction Medicine, 14(6), 297–302.
5. Cambridge Consultants. (2018). Clinical trials: How technology is driving digitisation. White paper. https://www.cambridgeconsultants.com/sites/default/files/uploaded-pdfs/Clinical%20trials%20-%20how%20technology%20is%20driving%20digitisation_1.pdf.